A Case for Norepinephrine versus Octreotide and Midodrine in Hepatorenal Syndrome

被引：0
|
作者：
Anong, John [1 ]
Litchfield, John [2 ]
Reddy, Chakradhar [2 ]
Borthwick, Thomas [2 ]
机构：
[1] E Tennessee State Univ, Dept Internal Med, Johnson City, TN 37614 USA
[2] E Tennessee State Univ, Dept Gastroenterol, Johnson City, TN 37614 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-00402
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
402
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [31] Terlipressin vs Midodrine Plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched Comparison
    Gonzalez, Stevan A.
    Chirikov, Viktor V.
    Wang, Wei-Jhih
    Huang, Xingyue
    Jamil, Khurram
    Simonetto, Douglas A.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2023, 14 (12)
  • [32] Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome
    Eric Esrailian
    Eugene R. Pantangco
    Namgyal L. Kyulo
    Ke-Qin Hu
    Bruce A. Runyon
    Digestive Diseases and Sciences, 2007, 52 : 742 - 748
  • [33] Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients
    Kaffy, F
    Borderie, C
    Chagneau, C
    Ripault, MP
    Larzillière, I
    Silvain, C
    Beauchant, M
    JOURNAL OF HEPATOLOGY, 1999, 30 (01) : 174 - 174
  • [34] Octreotide/midodrine therapy significantly improves survival in type 1 hepatorenal syndrome: Analysis of 53 treated patients & 21 controls
    Esrailian, E
    Pantangco, ER
    Kyulo, N
    Hu, KQ
    Runyon, BA
    GASTROENTEROLOGY, 2003, 124 (04) : A718 - A718
  • [35] Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome
    Esrailian, Eric
    Pantangco, Eugene R.
    Kyulo, Namgyal L.
    Hu, Ke-Qin
    Runyon, Bruce A.
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (03) : 742 - 748
  • [36] TERLIPRESSIN VERSUS MIDODRINE/ OCTREOTIDE AND THE NEED FOR RENAL REPLACEMENT THERAPY
    Yeary, Julianne
    Owen, Emily
    Juang, Paul
    CRITICAL CARE MEDICINE, 2024, 52
  • [37] Treatment With Albumin, Octreotide and Midodrine Is Effective as a Bridge to Liver Transplant in Both Hepatorenal Syndrome and Non HRS Acute Kidney Injury in Cirrhosis
    Voigt, M.
    Jain, A.
    Lawrence, H.
    TRANSPLANTATION, 2014, 98 : 181 - 181
  • [38] Treatment With Albumin, Octreotide and Midodrine Is Effective as a Bridge to Liver Transplant in Both Hepatorenal Syndrome and Non HRS Acute Kidney Injury in Cirrhosis
    Voigt, M.
    Jain, A.
    Lawrence, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 181 - 181
  • [39] Effect of octreotide on hepatorenal syndrome in cirrhotic patients.
    Kaffy, F
    Borderie, C
    Chagneau, C
    Ripault, MP
    Larzilliere, I
    Silvain, C
    Beauchant, M
    HEPATOLOGY, 1997, 26 (04) : 634 - 634
  • [40] Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis
    Nassar Junior, Antonio Paulo
    Farias, Alberto Queiroz
    Carneiro d' Albuquerque, Luiz Augusto
    Carrilho, Flair Jose
    Sa Malbouisson, Luiz Marcelo
    PLOS ONE, 2014, 9 (09):
12345